Cargando…

Optimal Range of Lymphadenectomy in Pathological Stage T1 and T2 Esophageal Squamous Cell Carcinoma

BACKGROUND: Lymph node metastasis is a primary contributor to tumor progression in esophageal squamous cell carcinoma (ESCC), and the optimal extent of lymphadenectomy during esophagectomy remains controversial. This study aimed to investigate the appropriate number of lymph nodes to be dissected in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Hansheng, Zhuang, Weitao, Huang, Shujie, Guan, Xueting, Zheng, Yuju, Xie, Zefeng, Chen, Gang, Tang, Jiming, Zhou, Haiyu, Xie, Liang, Ben, Xiaosong, Zhou, Zihao, Li, Zijun, Chen, Rixin, Qiao, Guibin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186312/ https://www.ncbi.nlm.nih.gov/pubmed/34113556 http://dx.doi.org/10.3389/fonc.2021.619556

Ejemplares similares

A novel prognostic model: which group of esophageal squamous cell carcinoma patients could benefit from adjuvant chemotherapy
por: Zhou, Zihao, et al.
Publicado: (2022)

The staging performance of a modified tumor-node-metastasis staging system incorporated with lymphovascular invasion in patients with esophageal squamous cell carcinoma
por: Zhuang, Weitao, et al.
Publicado: (2022)

A validated nomogram integrating hematological indicators to predict response to neoadjuvant therapy in esophageal squamous cell carcinoma patients
por: Wang, Sichao, et al.
Publicado: (2021)

Conversion Surgery Following Immunochemotherapy in Initially Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma—A Real-World Multicenter Study (RICE-Retro)
por: Huang, Shujie, et al.
Publicado: (2022)

Factors influencing negative surgical outcomes in adult pectus excavatum patients undergoing Nuss procedure
por: Gao, Zhen, et al.
Publicado: (2021)

m(6)A-binding protein IGF2BP1 promotes the malignant phenotypes of lung adenocarcinoma
por: Wu, Hansheng, et al.
Publicado: (2022)

Identification of a Ten-Gene Signature of DNA Damage Response Pathways with Prognostic Value in Esophageal Squamous Cell Carcinoma
por: Zhuang, Weitao, et al.
Publicado: (2021)

Accuracy of next-generation sequencing for molecular profiling of small specimen of lung cancer: a prospective pilot study of side-by-side comparison
por: Ben, Xiaosong, et al.
Publicado: (2022)

Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study
por: Qiao, Guibin, et al.
Publicado: (2021)

Surgical resection of primary tumors improved the prognosis of patients with bone metastasis of non-small cell lung cancer: a population-based and propensity score-matched study
por: Tian, Dan, et al.
Publicado: (2021)

Should psychological distress be listed as a surgical indication for indeterminate pulmonary nodules: protocol for a prospective cohort study in real-world settings
por: Zhuang, Weitao, et al.
Publicado: (2022)

Mechanical factors play an important role in pectus excavatum with thoracic scoliosis
por: Wang, Yuncang, et al.
Publicado: (2012)

Misconception contributed to COVID-19 vaccine hesitancy in patients with lung cancer or ground-glass opacity: a cross-sectional study of 324 Chinese patients
por: Zhuang, Weitao, et al.
Publicado: (2021)

Dynamic alteration in SULmax predicts early pathological tumor response and short-term prognosis in non-small cell lung cancer treated with neoadjuvant immunochemotherapy
por: Sun, Taotao, et al.
Publicado: (2022)

Risk factors associated with prolonged viral clearance in patients with a refractory course of COVID-19: a retrospective study
por: Zhuang, Weitao, et al.
Publicado: (2021)

Pregnancy-associated lung cancer: a clinical and scientific challenge more than treatment dilemma
por: Zhuang, Weitao, et al.
Publicado: (2021)

Salivary microbiota may predict the presence of esophageal squamous cell carcinoma
por: Wei, Junmin, et al.
Publicado: (2021)

Extent of Lymphadenectomy in Esophageal Cancer: How Many Lymph Nodes Is Enough?
por: Herrera, Luis J.
Publicado: (2009)

Robotic-assisted totally transhiatal lymphadenectomy in the middle mediastinum for esophageal cancer
por: Mori, Kazuhiko, et al.
Publicado: (2013)

Past, present, and future of three‐field lymphadenectomy for thoracic esophageal cancer
por: Udagawa, Harushi
Publicado: (2020)

Minimally invasive surgery vs. open thoracotomy for non-small-cell lung cancer with N2 disease: a systematic review and meta-analysis
por: Liu, Songlin, et al.
Publicado: (2023)

Persistent Somatic Symptom Burden and Sleep Disturbance in Patients with COVID-19 During Hospitalization and After Discharge: A Prospective Cohort Study
por: Huang, Shujie, et al.
Publicado: (2021)

The impact of lymphadenectomy on lymph node recurrence after performing various treatments for esophageal squamous cell carcinoma
por: Shigeno, Takashi, et al.
Publicado: (2022)

Mediastinal lymphadenectomy for esophageal cancer: Differences between two countries, Japan and the Netherlands
por: Cuesta, Miguel A., et al.
Publicado: (2018)

Adequate Lymphadenectomy as a Quality Measure in Esophageal Cancer: Is there an Association with Treatment Approach?
por: Schlick, Cary Jo R., et al.
Publicado: (2020)

COL19A1 is a predictive biomarker for the responsiveness of esophageal squamous cell carcinoma patients to immune checkpoint therapy
por: Liu, Jian‐Hua, et al.
Publicado: (2023)

Predictive value of the presence of Prevotella and the ratio of Porphyromonas gingivalis to Prevotella in saliva for esophageal squamous cell carcinoma
por: Chen, Xiaohui, et al.
Publicado: (2022)

Exploring the psychological profile: a cross-sectional study of 1,185 patients with pulmonary nodules in an outpatient clinic
por: Zhuang, Weitao, et al.
Publicado: (2022)

Does nivolumab combined with fluorouracil-based chemotherapy produce higher objective response rate than other immunochemotherapy regimes in metastatic esophageal cancer?: authors reply
por: Gao, Zhen, et al.
Publicado: (2023)

Efficacy and safety of immunochemotherapy, immunotherapy, chemotherapy, and targeted therapy as first-line treatment for advanced and metastatic esophageal cancer: a systematic review and network meta-analysis
por: Gao, Zhen, et al.
Publicado: (2023)

Prognostic Effect of the Dose of Radiation Therapy and Extent of Lymphadenectomy in Patients Receiving Neoadjuvant Chemoradiotherapy for Esophageal Squamous Carcinoma
por: Pai, Chu-Pin, et al.
Publicado: (2022)

Evidence-Based Operative Details in Esophageal Cancer Treatment: Surgical Approach, Lymphadenectomy, Anastomosis
por: Metzger, Ralf, et al.
Publicado: (2015)

Prognostic value of the extent of lymphadenectomy for esophageal cancer-specific survival among T1 patients
por: Wang, Yang, et al.
Publicado: (2021)

Selecting esophageal cancer patients for lymphadenectomy after neoadjuvant chemoradiotherapy: a modeling study
por: Scholte, Mirre, et al.
Publicado: (2020)

Achieving adequate lymph node dissection in treating esophageal squamous cell carcinomas by radical lymphadenectomy: Beyond the scope of numbers of harvested lymph nodes
por: Lin, Zheng, et al.
Publicado: (2019)

Thoracoscopic radical esophagectomy combined with left inferior pulmonary ligament lymphadenectomy for esophageal carcinoma via the right thoracic approach: A single-center retrospective study of 30 cases
por: Huang, Shijie, et al.
Publicado: (2021)

Salvage photodynamic therapy accompanied by extended lymphadenectomy for advanced esophageal carcinoma: A case report
por: Nishida, Takahiro, et al.
Publicado: (2017)

Differences in Esophageal Cancer Surgery in Terms of Surgical Approach and Extent of Lymphadenectomy: Findings of an International Survey
por: van Rijswijk, A. S., et al.
Publicado: (2019)

Meta-analysis of the efficacy of pancreatoduodenectomy with extended lymphadenectomy in the treatment of pancreatic cancer
por: Xu, Xinbao, et al.
Publicado: (2013)

What is paracervical lymphadenectomy?
por: Querleu, Denis, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hhq7vgr26pad3p7ipjfirhva31